4//SEC Filing
Poole Sandra 4
Accession 0001415889-24-012850
CIK 0001438533other
Filed
May 9, 8:00 PM ET
Accepted
May 10, 4:05 PM ET
Size
7.3 KB
Accession
0001415889-24-012850
Insider Transaction Report
Form 4
Poole Sandra
Director
Transactions
- Award
Common Stock
2024-05-08+6,500→ 23,500 total - Award
Stock option (right to buy)
2024-05-08+19,500→ 19,500 totalExercise: $6.82From: 2025-05-08Exp: 2034-05-07→ Common Stock (19,500 underlying)
Footnotes (2)
- [F1]Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program.
- [F2]The equity award vests over a one year period.
Documents
Issuer
Travere Therapeutics, Inc.
CIK 0001438533
Entity typeother
Related Parties
1- filerCIK 0001619622
Filing Metadata
- Form type
- 4
- Filed
- May 9, 8:00 PM ET
- Accepted
- May 10, 4:05 PM ET
- Size
- 7.3 KB